The Drugs Controller General of India (DCGI) recently approved the sale of Sofosbuvir-Ledipasvir combination, which is being manufactured in India under a license from Gilead.
- Biopharmaceutical company Biocon launched a generic version of Gilead Life sciences’ hepatitis C drug, Harvoni, in India.
- The novel therapy named CIMIVIR-L is a fixed dose combination of Ledipasvir 90 mg and Sofosbuvir 400 mg, and an improved version of Gilead’s blockbuster hepatitis C drug Sovaldi.
- Recently Natco Pharma has received a license from Gilead to sell a generic version of the drug in India, sells a bottle of 28 tablets at about Rs 20,000.
I think this is one of the most significant information for me. And i’m glad reading your article. But should remark on some general things, The web site style is perfect, the articles is really great : D. Good job, cheers generic harvoni
ReplyDelete